Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2002 Sep;87(2):F78–F82. doi: 10.1136/fn.87.2.F78

Retinopathy of prematurity: recent advances in our understanding

C Wheatley, J Dickinson, D Mackey, J Craig, M Sale
PMCID: PMC1721447  PMID: 12193510

Full Text

The Full Text of this article is available as a PDF (145.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N., WARD B., SERPELL G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954 Jul;38(7):397–432. doi: 10.1136/bjo.38.7.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AVERY M. E. Recent increase in mortality from hyaline membrane disease. J Pediatr. 1960 Oct;57:553–559. doi: 10.1016/s0022-3476(60)80083-2. [DOI] [PubMed] [Google Scholar]
  3. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995 Oct;1(10):1024–1028. doi: 10.1038/nm1095-1024. [DOI] [PubMed] [Google Scholar]
  4. Arnold R. W., Kesler K., Avila E. Susceptibility to retinopathy of prematurity in Alaskan Natives. J Pediatr Ophthalmol Strabismus. 1994 May-Jun;31(3):192–194. doi: 10.3928/0191-3913-19940501-12. [DOI] [PubMed] [Google Scholar]
  5. Arrøe M., Peitersen B. Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr. 1994 May;83(5):501–505. doi: 10.1111/j.1651-2227.1994.tb13067.x. [DOI] [PubMed] [Google Scholar]
  6. Ben Sira I., Nissenkorn I., Kremer I. Retinopathy of prematurity. Surv Ophthalmol. 1988 Jul-Aug;33(1):1–16. doi: 10.1016/0039-6257(88)90068-9. [DOI] [PubMed] [Google Scholar]
  7. Bergh T., Ericson A., Hillensjö T., Nygren K. G., Wennerholm U. B. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet. 1999 Nov 6;354(9190):1579–1585. doi: 10.1016/S0140-6736(99)04345-7. [DOI] [PubMed] [Google Scholar]
  8. Bullard S. R., Donahue S. P., Feman S. S., Sinatra R. B., Walsh W. F. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS. 1999 Feb;3(1):46–52. doi: 10.1016/s1091-8531(99)70094-7. [DOI] [PubMed] [Google Scholar]
  9. CAMPBELL K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. 1951 Jul 14;2(2):48–50. [PubMed] [Google Scholar]
  10. Chan-Ling T., Gock B., Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1201–1214. [PubMed] [Google Scholar]
  11. Chan-Ling T., Tout S., Holländer H., Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2128–2147. [PubMed] [Google Scholar]
  12. Chen Z. Y., Battinelli E. M., Fielder A., Bundey S., Sims K., Breakefield X. O., Craig I. W. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 1993 Oct;5(2):180–183. doi: 10.1038/ng1093-180. [DOI] [PubMed] [Google Scholar]
  13. Coats D. K., Paysse E. A., Steinkuller P. G. Threshold retinopathy of prematurity in neonates less than 25 weeks' estimated gestational age. J AAPOS. 2000 Jun;4(3):183–185. [PubMed] [Google Scholar]
  14. Criswick V. G., Schepens C. L. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969 Oct;68(4):578–594. doi: 10.1016/0002-9394(69)91237-9. [DOI] [PubMed] [Google Scholar]
  15. Cunningham S., Fleck B. W., Elton R. A., McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995 Dec 2;346(8988):1464–1465. doi: 10.1016/s0140-6736(95)92475-2. [DOI] [PubMed] [Google Scholar]
  16. Downey L. M., Keen T. J., Roberts E., Mansfield D. C., Bamashmus M., Inglehearn C. F. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am J Hum Genet. 2001 Jan 19;68(3):778–781. doi: 10.1086/318790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Englert J. A., Saunders R. A., Purohit D., Hulsey T. C., Ebeling M. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J Perinatol. 2001 Jan-Feb;21(1):21–26. doi: 10.1038/sj.jp.7200511. [DOI] [PubMed] [Google Scholar]
  18. Fledelius H. C. Retinopathy of prematurity in a Danish county. Trends over the 12-year period 1982-93. Acta Ophthalmol Scand. 1996 Jun;74(3):285–287. doi: 10.1111/j.1600-0420.1996.tb00093.x. [DOI] [PubMed] [Google Scholar]
  19. Flynn J. T. The premature retina: a model for the in vivo study of molecular genetics? Eye (Lond) 1992;6(Pt 2):161–165. doi: 10.1038/eye.1992.32. [DOI] [PubMed] [Google Scholar]
  20. Fuchs S., Kellner U., Wedemann H., Gal A. Missense mutation (Arg121Trp) in the Norrie disease gene associated with x-linked exudative vitreoretinopathy. Hum Mutat. 1995;6(3):257–259. doi: 10.1002/humu.1380060312. [DOI] [PubMed] [Google Scholar]
  21. Gibson D. L., Sheps S. B., Schechter M. T., Wiggins S., McCormick A. Q. Retinopathy of prematurity: a new epidemic? Pediatrics. 1989 Apr;83(4):486–492. [PubMed] [Google Scholar]
  22. Gilbert C., Foster A. Causes of blindness in children attending four schools for the blind in Thailand and the Philippines. A comparison between urban and rural blind school populations. Int Ophthalmol. 1993 Aug;17(4):229–234. doi: 10.1007/BF01007745. [DOI] [PubMed] [Google Scholar]
  23. Gilbert C., Foster A. Childhood blindness in the context of VISION 2020--the right to sight. Bull World Health Organ. 2003 Jul 7;79(3):227–232. [PMC free article] [PubMed] [Google Scholar]
  24. Gilbert C., Rahi J., Eckstein M., O'Sullivan J., Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997 Jul 5;350(9070):12–14. doi: 10.1016/S0140-6736(97)01107-0. [DOI] [PubMed] [Google Scholar]
  25. Hadi H. A., Hobbs C. L. Effect of chronic intrauterine stress on the disappearance of tunica vasculosa lentis of the fetal eye: a neonatal observation. Am J Perinatol. 1990 Jan;7(1):23–25. doi: 10.1055/s-2007-999438. [DOI] [PubMed] [Google Scholar]
  26. Haider M. Z., Devarajan L. V., Al-Essa M., Srivastva B. S., Kumar H., Azad R., Rashwan N. Missense mutations in norrie disease gene are not associated with advanced stages of retinopathy of prematurity in Kuwaiti arabs. Biol Neonate. 2000 Feb;77(2):88–91. doi: 10.1159/000014199. [DOI] [PubMed] [Google Scholar]
  27. Haider M. Z., Devarajan L. V., Al-Essa M., Srivastva B. S., Kumar H., Azad R., Rashwan N. Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages. Pediatr Int. 2001 Apr;43(2):120–123. doi: 10.1046/j.1442-200x.2001.01361.x. [DOI] [PubMed] [Google Scholar]
  28. Halsey C. L., Collin M. F., Anderson C. L. Extremely low birth weight children and their peers: a comparison of preschool performance. Pediatrics. 1993 Apr;91(4):807–811. [PubMed] [Google Scholar]
  29. Hatfield E. M. Blindness in infants and young children. Sight Sav Rev. 1972 Summer;42(2):69–89. [PubMed] [Google Scholar]
  30. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A. L., Liu J. L., Albertsson-Wikland K., Carlsson B., Niklasson A., Sjodell L. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001 May 1;98(10):5804–5808. doi: 10.1073/pnas.101113998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hiraoka M., Berinstein D. M., Trese M. T., Shastry B. S. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet. 2001;46(4):178–181. doi: 10.1007/s100380170085. [DOI] [PubMed] [Google Scholar]
  32. Hittner H. M., Godio L. B., Speer M. E., Rudolph A. J., Taylor M. M., Blifeld C., Kretzer F. L. Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant. Pediatrics. 1983 Mar;71(3):423–432. [PubMed] [Google Scholar]
  33. Huertas J. R., Palomino N., Ochoa J. J., Quiles J. L., Ramírez-Tortosa M. C., Battino M., Robles R., Mataix J. Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns. Biofactors. 1998;8(1-2):133–137. doi: 10.1002/biof.5520080122. [DOI] [PubMed] [Google Scholar]
  34. Hughes S., Yang H., Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1217–1228. [PubMed] [Google Scholar]
  35. Jacobson L., Fernell E., Broberger U., Ek U., Gillberg C. Children with blindness due to retinopathy of prematurity: a population-based study. Perinatal data, neurological and ophthalmological outcome. Dev Med Child Neurol. 1998 Mar;40(3):155–159. doi: 10.1111/j.1469-8749.1998.tb15439.x. [DOI] [PubMed] [Google Scholar]
  36. Karlowicz M. G., Giannone P. J., Pestian J., Morrow A. L., Shults J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (</=1000 g) neonates? Pediatrics. 2000 May;105(5):1036–1040. doi: 10.1542/peds.105.5.1036. [DOI] [PubMed] [Google Scholar]
  37. Katz M. L., Robison W. G., Jr Autoxidative damage to the retina: potential role in retinopathy of prematurity. Birth Defects Orig Artic Ser. 1988;24(1):237–248. [PubMed] [Google Scholar]
  38. Keith C. G., Doyle L. W., Kitchen W. H., Murton L. J. Retinopathy of prematurity in infants of 24-30 weeks' gestational age. Med J Aust. 1989 Mar 20;150(6):293–296. doi: 10.5694/j.1326-5377.1989.tb136487.x. [DOI] [PubMed] [Google Scholar]
  39. Kushner B. J., Essner D., Cohen I. J., Flynn J. T. Retrolental Fibroplasia. II. Pathologic correlation. Arch Ophthalmol. 1977 Jan;95(1):29–38. doi: 10.1001/archopht.1977.04450010031002. [DOI] [PubMed] [Google Scholar]
  40. Lashkari K., Hirose T., Yazdany J., McMeel J. W., Kazlauskas A., Rahimi N. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000 Apr;156(4):1337–1344. doi: 10.1016/S0002-9440(10)65004-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lee S. K., Normand C., McMillan D., Ohlsson A., Vincer M., Lyons C., Canadian Neonatal Network Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med. 2001 Mar;155(3):387–395. doi: 10.1001/archpedi.155.3.387. [DOI] [PubMed] [Google Scholar]
  42. Leo S. W., Cheong P. Y. Incidence of retinopathy of prematurity in Singapore. Singapore Med J. 1997 Feb;38(2):54–57. [PubMed] [Google Scholar]
  43. McKibbin M., Dabbs T. R. Assisted conception and retinopathy of prematurity. Eye (Lond) 1996;10(Pt 4):476–478. doi: 10.1038/eye.1996.105. [DOI] [PubMed] [Google Scholar]
  44. McLeod D. S., Brownstein R., Lutty G. A. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 1996 Feb;37(2):300–311. [PubMed] [Google Scholar]
  45. Meindl A., Lorenz B., Achatz H., Hellebrand H., Schmitz-Valckenberg P., Meitinger T. Missense mutations in the NDP gene in patients with a less severe course of Norrie disease. Hum Mol Genet. 1995 Mar;4(3):489–490. doi: 10.1093/hmg/4.3.489. [DOI] [PubMed] [Google Scholar]
  46. Mets M. B. Childhood blindness and visual loss: an assessment at two institutions including a "new" cause. Trans Am Ophthalmol Soc. 1999;97:653–696. [PMC free article] [PubMed] [Google Scholar]
  47. Mintz-Hittner H. A., Ferrell R. E., Sims K. B., Fernandez K. M., Gemmell B. S., Satriano D. R., Caster J., Kretzer F. L. Peripheral retinopathy in offspring of carriers of Norrie disease gene mutations. Possible transplacental effect of abnormal Norrin. Ophthalmology. 1996 Dec;103(12):2128–2134. doi: 10.1016/s0161-6420(96)30379-5. [DOI] [PubMed] [Google Scholar]
  48. Nødgaard H., Andreasen H., Hansen H., Sørensen H. T. Risk factors associated with retinopathy of prematurity (ROP) in northern Jutland, Denmark 1990-1993. Acta Ophthalmol Scand. 1996 Jun;74(3):306–310. doi: 10.1111/j.1600-0420.1996.tb00098.x. [DOI] [PubMed] [Google Scholar]
  49. Okamoto N., Tobe T., Hackett S. F., Ozaki H., Vinores M. A., LaRochelle W., Zack D. J., Campochiaro P. A. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997 Jul;151(1):281–291. [PMC free article] [PubMed] [Google Scholar]
  50. Ott S., Patel R. J., Appukuttan B., Wang X., Stout J. T. A novel mutation in the Norrie disease gene. J AAPOS. 2000 Apr;4(2):125–126. doi: 10.1067/mpa.2000.103874. [DOI] [PubMed] [Google Scholar]
  51. PATZ A., HOECK L. E., DE LA CRUZ E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952 Sep;35(9):1248–1253. doi: 10.1016/0002-9394(52)91140-9. [DOI] [PubMed] [Google Scholar]
  52. Penn J. S., Henry M. M., Tolman B. L. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res. 1994 Dec;36(6):724–731. doi: 10.1203/00006450-199412000-00007. [DOI] [PubMed] [Google Scholar]
  53. Pennefather P. M., Tin W. Ocular abnormalities associated with cerebral palsy after preterm birth. Eye (Lond) 2000 Feb;14(Pt 1):78–81. doi: 10.1038/eye.2000.17. [DOI] [PubMed] [Google Scholar]
  54. Phelps D. L. Retinopathy of prematurity: an estimate of vision loss in the United States--1979. Pediatrics. 1981 Jun;67(6):924–925. [PubMed] [Google Scholar]
  55. Plager D. A., Orgel I. K., Ellis F. D., Hartzer M., Trese M. T., Shastry B. S. X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol. 1992 Aug 15;114(2):145–148. doi: 10.1016/s0002-9394(14)73977-7. [DOI] [PubMed] [Google Scholar]
  56. Price S. M., Periam N., Humphries A., Woodruff G., Trembath R. C. Familial exudative vitreoretinopathy linked to D11S533 in a large Asian family with consanguinity. Ophthalmic Genet. 1996 Jun;17(2):53–57. doi: 10.3109/13816819609057871. [DOI] [PubMed] [Google Scholar]
  57. Reynolds J. D., Hardy R. J., Kennedy K. A., Spencer R., van Heuven W. A., Fielder A. R. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med. 1998 May 28;338(22):1572–1576. doi: 10.1056/NEJM199805283382202. [DOI] [PubMed] [Google Scholar]
  58. Robbins S. G., Conaway J. R., Ford B. L., Roberto K. A., Penn J. S. Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina. Growth Factors. 1997;14(4):229–241. doi: 10.3109/08977199709021522. [DOI] [PubMed] [Google Scholar]
  59. Robbins S. G., Rajaratnam V. S., Penn J. S. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. Growth Factors. 1998;16(1):1–9. doi: 10.3109/08977199809017487. [DOI] [PubMed] [Google Scholar]
  60. Rowlands E., Ionides A. C., Chinn S., Mackinnon H., Davey C. C. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol. 2001 Aug;85(8):933–935. doi: 10.1136/bjo.85.8.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Saunders R. A., Donahue M. L., Christmann L. M., Pakalnis A. V., Tung B., Hardy R. J., Phelps D. L. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1997 May;115(5):604–608. doi: 10.1001/archopht.1997.01100150606005. [DOI] [PubMed] [Google Scholar]
  62. Schaffer D. B., Palmer E. A., Plotsky D. F., Metz H. S., Flynn J. T., Tung B., Hardy R. J. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993 Feb;100(2):230–237. doi: 10.1016/s0161-6420(93)31665-9. [DOI] [PubMed] [Google Scholar]
  63. Schuback D. E., Chen Z. Y., Craig I. W., Breakefield X. O., Sims K. B. Mutations in the Norrie disease gene. Hum Mutat. 1995;5(4):285–292. doi: 10.1002/humu.1380050403. [DOI] [PubMed] [Google Scholar]
  64. Seiberth V., Linderkamp O. Risk factors in retinopathy of prematurity. a multivariate statistical analysis. Ophthalmologica. 2000;214(2):131–135. doi: 10.1159/000027482. [DOI] [PubMed] [Google Scholar]
  65. Shastry B. S., Hejtmancik J. F., Trese M. T. Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat. 1997;9(5):396–401. doi: 10.1002/(SICI)1098-1004(1997)9:5<396::AID-HUMU3>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  66. Shastry B. S., Hiraoka M., Trese D. C., Trese M. T. Norrie disease and exudative vitreoretinopathy in families with affected female carriers. Eur J Ophthalmol. 1999 Jul-Sep;9(3):238–242. doi: 10.1177/112067219900900312. [DOI] [PubMed] [Google Scholar]
  67. Shastry B. S., Pendergast S. D., Hartzer M. K., Liu X., Trese M. T. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997 May;115(5):651–655. doi: 10.1001/archopht.1997.01100150653015. [DOI] [PubMed] [Google Scholar]
  68. Shohat M., Reisner S. H., Krikler R., Nissenkorn I., Yassur Y., Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics. 1983 Aug;72(2):159–163. [PubMed] [Google Scholar]
  69. Sims K. B., Irvine A. R., Good W. V. Norrie disease in a family with a manifesting female carrier. Arch Ophthalmol. 1997 Apr;115(4):517–519. doi: 10.1001/archopht.1997.01100150519012. [DOI] [PubMed] [Google Scholar]
  70. Steinkuller P. G., Du L., Gilbert C., Foster A., Collins M. L., Coats D. K. Childhood blindness. J AAPOS. 1999 Feb;3(1):26–32. doi: 10.1016/s1091-8531(99)70091-1. [DOI] [PubMed] [Google Scholar]
  71. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000 Feb;105(2):295–310. doi: 10.1542/peds.105.2.295. [DOI] [PubMed] [Google Scholar]
  72. Tamai H., Majima A. Implications of the severity of retinopathy of prematurity on childhood development. Jpn J Ophthalmol. 1996;40(3):371–376. [PubMed] [Google Scholar]
  73. Thieme H., Aiello L. P., Takagi H., Ferrara N., King G. L. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995 Jan;44(1):98–103. doi: 10.2337/diab.44.1.98. [DOI] [PubMed] [Google Scholar]
  74. Thylefors B. A global initiative for the elimination of avoidable blindness. Am J Ophthalmol. 1998 Jan;125(1):90–93. doi: 10.1016/s0002-9394(99)80239-6. [DOI] [PubMed] [Google Scholar]
  75. Todd D. A., Kennedy J., Cassell C., Roberts S., John E. Retinopathy of prematurity in infants <29 weeks' gestation at birth in New South Wales from 1986-92. J Paediatr Child Health. 1998 Feb;34(1):32–36. doi: 10.1046/j.1440-1754.1998.00149.x. [DOI] [PubMed] [Google Scholar]
  76. Todd D. A., Kennedy J., Roberts S., Watts J., Psaila K., John E. Retinopathy of prematurity in infants less than 29 weeks' gestation at birth. Aust N Z J Ophthalmol. 1994 Feb;22(1):19–23. doi: 10.1111/j.1442-9071.1994.tb01690.x. [DOI] [PubMed] [Google Scholar]
  77. Todd D., Cassell C., Kennedy J., John E. Retinopathy of prematurity in infants < 32 weeks' gestation at birth in New South Wales in 1993 and 1994. J Paediatr Child Health. 1999 Aug;35(4):355–357. [PubMed] [Google Scholar]
  78. Todd D., Kennedy J., Roberts V., John E. Risk factors in progression beyond stage 2 retinopathy of prematurity. Aust N Z J Ophthalmol. 1990 Feb;18(1):57–60. doi: 10.1111/j.1442-9071.1990.tb00585.x. [DOI] [PubMed] [Google Scholar]
  79. Tolentino M. J., Miller J. W., Gragoudas E. S., Chatzistefanou K., Ferrara N., Adamis A. P. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996 Aug;114(8):964–970. doi: 10.1001/archopht.1996.01100140172010. [DOI] [PubMed] [Google Scholar]
  80. Valentine P. H., Jackson J. C., Kalina R. E., Woodrum D. E. Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity. Pediatrics. 1989 Sep;84(3):442–445. [PubMed] [Google Scholar]
  81. Vyas J., Field D., Draper E. S., Woodruff G., Fielder A. R., Thompson J., Shaw N. J., Clark D., Gregson R., Burke J. Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight. Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F145–F149. doi: 10.1136/fn.82.2.F145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Wallace D. K., Kylstra J. A., Phillips S. J., Hall J. G. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS. 2000 Dec;4(6):343–347. doi: 10.1067/mpa.2000.110342. [DOI] [PubMed] [Google Scholar]
  83. Watts P., Adams G. G. In vitro fertilisation and stage 3 retinopathy of prematurity. Eye (Lond) 2000 Jun;14(Pt 3A):330–333. doi: 10.1038/eye.2000.82. [DOI] [PubMed] [Google Scholar]
  84. Weerakoon I. K., Fonseka C. Retinopathy of prematurity in Sri Lanka. Ceylon Med J. 1998 Dec;43(4):194–195. [PubMed] [Google Scholar]
  85. Whitfill C. R., Drack A. V. Avoidance and treatment of retinopathy of prematurity. Semin Pediatr Surg. 2000 May;9(2):103–105. doi: 10.1016/s1055-8586(00)70025-4. [DOI] [PubMed] [Google Scholar]
  86. de Crecchio G., Simonelli F., Nunziata G., Mazzeo S., Greco G. M., Rinaldi E., Ventruto V., Ciccodicola A., Miano M. G., Testa F. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet. 1998 Oct;54(4):315–320. doi: 10.1034/j.1399-0004.1998.5440409.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES